iDCF: Interpretable deconvolution of cell fractions via biologically-informed deep learning using scRNA-seq data
Hongjiang Guo, Tingfang Wu, Wenzheng Wang, Yelu Jiang et autres
0 citationsPLoS Computational Biology
Bristol-Myers Squibb (India)
Mumbai · IN · company
536Publications signalées
32221Citations signalées
12Thèmes principaux
Principaux domaines
Drug Transport and Resistance MechanismsAnalytical Chemistry and ChromatographyChemical Synthesis and AnalysisHIV/AIDS drug development and treatmentPharmacogenetics and Drug MetabolismPharmacological Effects and Toxicity StudiesComputational Drug Discovery MethodsCatalytic C–H Functionalization MethodsSynthesis and Biological EvaluationAcute Myeloid Leukemia ResearchFluorine in Organic ChemistryImmune Response and Inflammation
Évolution annuelle
Publications récentes
Discovery of BMS-986449: A Potent, Selective Degrader of the Transcription Factors IKZF2 (Helios) and IKZF4 (Eos) to Target Regulatory T Cells in Solid Tumors
Emily C. Cherney, Satheesh K. Nair, Suresh Babu Viswa Krishna Penmetsa, Bharat Shimpukade et autres
0 citationsJournal of Medicinal Chemistry
Imaging the fate of CAR-T cells in vivo
Hongyi Wang, Yan Yan, Yueping Li, Sihan Chen et autres
0 citationsFrontiers in Immunology
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer
Tina Cascone, Mark M. Awad, Jonathan Spicer, Jie He et autres
1 citationNature
Implementation of a colorimetry-based urinary biomarker screening system for early UTI risk detection
H. M. Monisha, R. Rashmi, Nethra Sureshkumar, Rida Rabeea Fatima et autres
0 citationsScientific Reports
Evolution of treatment distribution and patient characteristics of muscle invasive bladder cancer patients: results from two multi-national real-world surveys
M. PATEL, Xingzhi Wang, Renita Castelino, Neil Milloy et autres
0 citationsBMC Urology
POSTER: ABCL-142: Golcadomide—A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy
Muhamad Alhaj Moustafa, Theodoros Vassilakopoulos, Grzegorz Nowakowski, Michal Kwiatek et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
MDS-113: Updated Overall Survival and Long-Term Transfusion Independence From the Phase 3 COMMANDS Trial in Erythropoiesis-Stimulating Agent–Naïve Patients With Lower-Risk Myelodysplastic Syndromes
Guillermo Garcia-Manero, Matteo Giovanni Della Porta, Amer M Zeidan, Rami S. Komrokji et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
ABCL-142: Golcadomide—A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy
Muhamad Alhaj Moustafa, Theodoros Vassilakopoulos, Grzegorz Nowakowski, Michal Kwiatek et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
POSTER: MDS-113: Updated Overall Survival and Long-Term Transfusion Independence From the Phase 3 COMMANDS Trial in Erythropoiesis-Stimulating Agent–Naïve Patients With Lower-Risk Myelodysplastic Syndromes
Guillermo Garcia-Manero, Matteo Giovanni Della Porta, Amer M Zeidan, Rami S. Komrokji et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
Development of a smart root canal sealer capable of releasing antimicrobial agents in response to pH changes
0 citations
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Elham Omer Mahgoub, Syed Asif Husain
0 citationsJournal of Visualized Experiments
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.